ADMA Biologics Inc Share Price
NASDAQ: ADMA | Mid CapADMA Biologics Inc Stock Performance
Open $9.47 | Prev. Close $9.48 | Circuit Range N/A |
Day Range $9.34 - $9.51 | Year Range $7.23 - $20.43 | Volume 1,22,518 |
Average Traded $9.40 |
ADMA Biologics Inc Share Price Today
As of 29 August 2026, ADMA Biologics Inc's share price is $9.35. The stock opened at $9.47, compared to its previous close of $9.48. During today's trading session, ADMA Biologics Inc's share price traded between $9.34 and $9.51, with an average price of $9.43. Over the past 52 weeks, the stock has recorded a high of $20.43 and a low of $7.23. In terms of performance, ADMA Biologics Inc's share price has declined by 39.97% over the last six months and is down 45.81% on a year-on-year basis.
ADMA Biologics Inc Share Price Chart
ADMA Biologics Inc Stock Fundamentals & Key Indicators
Market Cap $2.23B | PE Ratio (TTM) 15.08 | Dividend Yield N/A |
EPS (TTM) $0.62 | Revenue (TTM) $510.17M | Return On Equity (TTM) 30.78% |
Profit Margin 28.80% | Debt to Equity 0.15 | Quarterly Earnings Growth YoY 1.45% |
ADMA Biologics Inc Quarterly Profit & Loss
All figures in USD
ADMA Biologics Inc Annual Profit & Loss
All figures in USD
About ADMA Biologics Inc
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
ADMA Biologics Inc Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $8.61 | $9.48 | +12.06% |
Jul 2026 | $8.57 | $8.46 | +1.01% |
Jun 2026 | $7.96 | $8.38 | +5.21% |
May 2026 | $10.40 | $7.96 | -22.27% |
Apr 2026 | $9.04 | $10.24 | +13.90% |
Mar 2026 | $15.74 | $8.99 | -42.28% |
Feb 2026 | $17.23 | $15.57 | -9.92% |
Jan 2026 | $18.44 | $17.29 | -5.16% |
Dec 2025 | $18.94 | $18.23 | -4.90% |
Nov 2025 | $15.45 | $19.17 | +23.92% |
Oct 2025 | $14.73 | $15.47 | +5.56% |
Sep 2025 | $17.11 | $14.65 | -15.07% |
ADMA Share Price FAQs
What is ADMA Biologics Inc share price today?
What is the 52 week high and 52 week low of ADMA Biologics Inc stock?
What is ADMA's market capitalisation today?
What is ADMA's net income for the last quarter?
What is the 5 year returns of ADMA?
What is the high & low stock price of ADMA today?
Can I buy ADMA shares in India?